Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Lipoproteins and atherogenesis

¹Section of Cell Biology, Molecular Disease Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.

Endocrinology and Metabolism Clinics of North America

|October 24, 1998

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Lecithin-cholesterol acyltransferase: role in lipoprotein metabolism, reverse cholesterol transport and atherosclerosis.

Current opinion in lipidology·2000

Same author

Superovulation of rabbits with FSH alters in vivo development of vitrified morulae.

Theriogenology·2000

Same author

LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits.

Arteriosclerosis, thrombosis, and vascular biology·2000

Same author

Transgenic rabbits as models for atherosclerosis research.

Journal of lipid research·1999

Same author

Evaluation of the aortic root by MRI: insights from patients with homozygous familial hypercholesterolemia.

Circulation·1998

Same author

Correction of hypoalphalipoproteinemia in LDL receptor-deficient rabbits by lecithin:cholesterol acyltransferase.

Journal of lipid research·1998

Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026

Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026

Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026

Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026

Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026

Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026

See all related articles

Atherogenesis, a complex vascular disease, arises from genetic and environmental factors. Understanding lipoprotein subspecies concentrations aids in identifying at-risk patients and developing prevention strategies.

Area of Science:

Cardiovascular Science
Genetics
Epidemiology

Background:

Atherogenesis is a complex vascular disease influenced by numerous genetic and environmental factors.
No single cause has been identified for this indolent vascular condition.
Cholesterol-enriched lipoprotein particles are strongly associated with disease development.

Purpose of the Study:

To explore the interplay of genetic and environmental factors in atherogenesis.
To understand the role of lipoprotein subspecies in disease risk.
To inform therapeutic strategies for preventing atherogenesis.

Main Methods:

Review of nonhuman animal models.
Investigation of epidemiologic factors in human populations.
Analysis of genetic and environmental influences on lipoprotein concentrations.

Related Experiment Videos

Main Results:

Atherogenesis results from a combination of genetic and environmental influences.
Specific lipoprotein subspecies concentrations are key indicators.
Identifying these influences helps in risk assessment.

Conclusions:

Genetic and environmental factors significantly impact lipoprotein levels, influencing atherogenesis risk.
Targeting lipoprotein subspecies offers potential therapeutic avenues.
Further research into these interactions can lead to effective prevention and treatment strategies.